729 results on '"Kusano, Motoyasu"'
Search Results
2. Evidence-based clinical practice guidelines for functional dyspepsia 2021
3. Utility of a new automated diagnostic program in high-resolution esophageal manometry
4. Impact of improvement of sleep disturbance on symptoms and quality of life in patients with functional dyspepsia
5. Correction to: Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1 and Part 2
6. Herbal Medicine
7. Clinical impact of different cut-off values in high-resolution manometry systems on diagnosing esophageal motility disorders
8. Relationship between esophageal motility abnormalities and skin or lung involvements in patients with systemic sclerosis
9. Efficacy and Safety Profile of Z-215 (Azeloprazole Sodium), a Proton Pump Inhibitor, Compared with Rabeprazole Sodium in Patients with Reflux Esophagitis: A Phase II, Multicenter, Randomized, Double-Blind, Comparative Study
10. Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2
11. Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1
12. Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study
13. Higher frequency of upper gastrointestinal symptoms in healthy young Japanese females compared to males and older generations
14. Response to the letter by Dr. Costa-Moreira, Dr. Peixoto, Dr. Ramalho, and Dr. Macedo regarding our manuscript: “Relationship between esophageal motility abnormalities and skin or lung involvements in patients with systemic sclerosis”
15. Decreased risk of esophageal cancer owing to cigarette and alcohol cessation in smokers and drinkers: a systematic review and meta-analysis
16. Helicobacter pylori infection status had no influence on upper gastrointestinal symptoms: a cross-sectional analysis of 3,005 Japanese subjects without upper gastrointestinal lesions undergoing medical health checkups
17. New endoscopic classification of cascade stomach, a risk factor for reflux esophagitis
18. Sodium Glucose Cotransporter 2 Inhibition Combined With Cetuximab Significantly Reduced Tumor Size and Carcinoembryonic Antigen Level in Colon Cancer Metastatic to Liver
19. Therapy of gastroesophageal reflux disease and functional dyspepsia overlaps with symptoms after usual‐dose proton pump inhibitor: Acotiamide plus usual‐dose proton pump inhibitor versus double‐dose proton pump inhibitor
20. Elevated serum uric acid level was a notable adverse event during combination therapy with sofosbuvir and ribavirin
21. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015
22. Neo-adjuvant therapy or definitive chemoradiotherapy can improve laryngeal preservation rates in patients with cervical esophageal cancer. A Japanese nationwide survey
23. A nation-wide survey of follow-up strategies for esophageal cancer patients after a curative esophagectomy or a complete response by definitive chemoradiotherapy in Japan
24. Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery
25. Endoscopic treatment for esophageal varices complicated by Isaacs' syndrome involving difficulty with conventional sedation
26. Spontaneous remission of hepatitis B virus reactivation during direct‐acting antiviral agent‐based therapy for chronic hepatitis C
27. Risk factors for low response to proton-pump inhibitor treatment in reflux esophagitis and non-erosive reflux disease evaluated by the frequency scale for the symptoms of gastroesophageal reflux disease
28. More severe upper gastrointestinal symptoms associated with non-erosive reflux disease than with erosive gastroesophageal reflux disease during maintenance proton pump inhibitor therapy
29. Evidence-based clinical practice guidelines for functional dyspepsia
30. Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society
31. A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor: the G-PRIDE study
32. New Frontiers in Gut Nutrient Sensor Research: Monosodium l-Glutamate Added to a High-Energy, High-Protein Liquid Diet Promotes Gastric Emptying: a Possible Therapy for Patients With Functional Dyspepsia
33. # 1439 Three cases of the hepatitis C patients that presented hyperkalemia during daclatasvir and asunaprevir combination therapy
34. # 1018 Hepatic angiosarcoma with dyskeratosis congenita
35. # 1093 Malignant peripheral nerve sheath tumor of the liver
36. # 1017 Fecal lactoferrin is a useful biomarker for mucosal healing in cases of ulcerative colitis during monocyte adsorptive apheresis therapy
37. # 1011 A case of endoscopic treatment for esophageal varices complicated by Isaacsʼ syndrome involving difficulty with conventional sedation
38. # 1132 Shortening the procedure time of pancreatobiliary endoscopy using a short guidewire in combination with the side lock technique
39. A Case of Proton Pump Inhibitor–Resistant Multiple Gastric Ulcers Caused by Eosinophilic Gastroenteritis
40. Monosodium l-glutamate added to a high-energy, high-protein liquid diet promotes gastric emptying
41. Rikkunshito improves symptoms in PPI-refractory GERD patients: a prospective, randomized, multicenter trial in Japan
42. Combination of angiotensin II receptor blockers promotes proton pump inhibitor-based healing of reflux esophagitis
43. Investigation of pretreatment prediction of proton pump inhibitor (PPI)-resistant patients with gastroesophageal reflux disease and the dose escalation challenge of PPIs—TORNADO study: a multicenter prospective study by the Acid-Related Symptom Research Group in Japan
44. Paget’s disease of bone resembling bone metastasis from gastric cancer
45. Survey on the prevalence of GERD and FD based on the Montreal definition and the Rome III criteria among patients presenting with epigastric symptoms in Japan
46. Effect of rabeprazole treatment on health-related quality of life and symptoms in patients with reflux esophagitis: a prospective multicenter observational study in Japan
47. A double-blind, controlled study comparing lafutidine with placebo and famotidine in Japanese patients with mild reflux esophagitis
48. Effect of acotiamide on gastric emptying in healthy adult humans
49. Reflux esophagitis in young healthy Japanese medical school students evaluated by endoscopy and FSSG: P-199
50. It Is Possible to Classify Non-erosive Reflux Disease (NERD) Patients into Endoscopically Normal Groups and Minimal Change Groups by Subjective Symptoms and Responsiveness to Rabeprazole—A Report from a Study with Japanese Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.